The AES Corporation

0H6G.L·LSE
Compare
14.98+0.04 (+0.23%)today
At close: Oct 22, 5:32 PM BST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close14.94
Open14.91
Day range14.9114.99
52-week range11.5225.49
Off day high−0.10%
Off 52-week high−41.25%
Volume696
Avg. volume (3M)5.08K
Market cap—
EPS (TTM)-0.2230
Forward P/E—
P/E ratio (TTM)—
Dividend yield4.71% (0.7040)
Beta (5Y)0.95
Shares outstanding662.30M
Short interest—
Earnings dateNov 4, 2026 (est.)
Analyst target—
Profit margin14.34%

Against its peers

Compare in full ›
0H6G.L AEP QESS.CN AGL.AX BESS EOAN.F
Market cap — 71.12B 38.42M 5.99B 13.70M 47.87B
P/E (TTM) — 22.6 — 7.8 — 14.2
Forward P/E — 19.0 — 12.5 1.1 14.7
Price/book 2.2 2.2 9.3 1.1 0.4 2.3
Dividend yield 4.71% 3.05% — 5.92% — 3.17%
1-year change −32.02% +9.65% −31.71% −3.37% −78.26% +13.95%
Today +0.23% +2.55% −7.14% +1.37% −3.50% +0.60%

The closest companies by business. Prices may be delayed up to 20 min.

Latest news

All 0H6G.L news ›
The Globe and Mail·Negative

AES Merger Gains Key Regulatory Approvals in Europe, US

The latest update is out from AES ( (AES) ). The most recent analyst rating on (AES) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on AES stock, see the AES Stock Forecast page. Spark’s Take on AES…

@onclive·Negative

AE Profile and Discontinuation Rate in Cohort 1

Paul L. Swiecicki, MD, of the University of Michigan Rogel Cancer Center, characterizes the safety and tolerability of subcutaneous amivantamab monotherapy in cohort 1 of the OrigAMI-4 study. He reports that the profile was consistent with…

@onclive·Negative

Counseling and Proactive AE Management vs. Cetuximab

Paul L. Swiecicki, MD, of the University of Michigan Rogel Cancer Center, discusses how community oncologists should counsel and manage adverse events (AEs) with subcutaneous amivantamab in head and neck squamous cell carcinoma. He notes…

BIOENGINEER.ORG·Negative

Bio-Inspired Alignment Cut AES Trace Needs in Preliminary Test

One target contained an STM32F3 microcontroller with an Arm Cortex-M3 core, while the other used an FE310-G002 with a RISC-V core. A ChipWhisperer-Lite sampled synchronously at approximately 29.5 million samples per second, using a…

Mixonline·Negative

WSDG Set for AES Show 2026 Nashville

Nashville, TN (October 20, 2026)—The AES Nashville 2026 convention is right around the corner, taking place across Halloween weekend at the Gaylord Opryland Resort & Convention Center, and WSDG will be there to share its insights and…

From articles in the 4Search news index.

In the news

90mentions in 30 days
90with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 90 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.